Current stage-Stage III-III-A Posts on Medivizor
Navigation Menu

Current stage-Stage III-III-A Posts on Medivizor

Comparing gene-targeting therapy to standard chemotherapy in patients with early stage NSCLC

Posted by on Apr 9, 2018 in Lung cancer | 0 comments

In a nutshell This study compared gefitinib (Iressa) to cisplatin (Platinol)-based chemotherapy for treating patients with EGFR-mutation positive, early stage non-small-cell lung cancer, after surgery. The authors concluded that while treatment with gefitinib improved disease free survival compared to chemotherapy, they were unable to calculate overall...

Read More

Recommendations on adjuvant therapy for patients with early stage non-small-cell lung cancer

Posted by on Aug 5, 2017 in Lung cancer | 0 comments

In a nutshell This article presents updated guidelines on treating non-small cell lung cancer patients with adjuvant (following surgery) chemotherapy or radiation. The authors provide recommendations on when to use adjuvant therapy based primarily on disease stage. Some background Cancer patients who have tumors removed by surgery often undergo...

Read More

Benefits of preventive radiation therapy to the head in stage III-N2 non-small cell lung cancer

Posted by on Jun 14, 2015 in Lung cancer | 0 comments

In a nutshell The authors evaluated the benefits of preventive radiation therapy in patients with non-small cell lung cancer (NSCLC) who have high risk of developing brain metastases (spreading of cancer from the lungs to the brain). Some background NSCLC is the most common type of lung cancer, accounting for 85% of all lung cancers. In...

Read More

Is a unique paclitaxel plus trastuzumab treatment effective in HER2 positive breast cancer?

Posted by on Apr 7, 2015 in Breast cancer | 0 comments

In a nutshell This paper studied the safety and effectiveness of treatment with a unique form of paclitaxel (Taxol) and trastuzumab (Herceptin) in human epidermal growth factor receptor 2 positive breast cancer.  Some background Chemotherapy is widely used before surgery in breast cancer to reduce the size of the tumour before surgical...

Read More

Progesterone receptors and cancer prognosis

Posted by on Apr 22, 2014 in Breast cancer | 0 comments

In a nutshell This study evaluated the use of progesterone receptor status as an independent predictor of disease prognosis in patients with early breast cancer. Some background Most breast cancer cells grow in response to female hormones, such as progesterone and estrogen. Cancer response to these growth stimuli not only directs treatment...

Read More

Removing the lymph nodes, not just the cancer

Posted by on Sep 25, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of lateral pelvic lymph node dissection on survival of rectal cancer patients. Some background Removal of the lymph nodes in the area surrounding lower rectal cancer (lateral pelvic lymph node dissection or LPND) is often performed during surgery to remove the cancer. LPND is usually performed if...

Read More